Canine Parvovirus
- (CPV-@) (MLV)
|
Administer at 6-8
wks of age, then every 3-4 wks until 12-14 weeks of age |
PARVOVIRUS
Two doses, 3-4 weeks apart. One dose
is considered protective and acceptable |
After a booster at
1 yr (unless mfg. label recommends otherwise) revaccination
once every 3 yrs or more is considered protective |
Core:
Although annual boosters are recommended by some vaccine
mfg. studies have shown protection against challenge (DOI)up
to 7 yrs posst vaccination with MLVvaccine products with
CPV-2 all provide excellent protection against field
isolates. |
Canine Parvovirus
- CPV-2 (killed)
|
|
|
|
Not
recommended killed parvovirus products have been
shown to be susceptible to maternal antibody interference in
puppies as old as 16-18 wks . Multiple doses (2-5) may
be required even if puppies oldaer than 12 wks |
Canine Distemper
- Virus (CDV) (MLV)
|
Administer at 6-8
wks of age, then every 3-4 wks until 12-14 wks of age |
DISTEMPER
Two doses , 3-4 weeks apart. One
dose is considered protective and acceptable. |
After a booster at
1 yr (unless mfg recommends)revaccination once
every 3 yrs or more is considered protective. |
Core:
Although annual boosters are recommended by some mfg , adult
dogs, challenged 7 yrs following vacinnation were protected |
Canine Distemper
- Virus (rCDV)
|
Administer at 6-8
wks of age, the 3-4 wks apart until 12-14 wks of age |
DISTEMPER
Two doses-3-4 wks apart |
After a booster at
1 yr revaccination
every 3 yrs is protective |
A suitable
alternative to the MLV-CDV vaccine Recent studies have shown
compared with MLV_CDV vaccines the recomvinant CDV is more
likely to immunize puppies in the face of passively acquired
maternal antibody |
Distemper-
- Measles Virus
- (D-MV)(MLV)
|
One dose only
between 4-12 wks |
MEASLES
Never indicated in animals older than 12
wks |
Never
indicated in animals older than 12 wks |
Noncore:
Intended to provide temporary protection in
- puppies because the measles vaccine is
effective at providing immunity against CDV even in the
presence of passively acquired maternal antibody
|
| Canine
Adenovirus-1(Cav-1) (MLV) and killed |
|
|
|
Not
recommended : Significant risk of "hepatitis
blue-eye reactions is associated with CAV-1 vaccines.
CAV-2 vaccines very effectively cross-protect against CAV-1
and are much safer. |
| Canine
Adenovirus-2(CAV-2) (MLV parenteral) |
Administer at 6-8
wks of age, then every 3-4 wks until 12-14 wks |
ADENOVIRUS
Two doses 3-4 wks apart. One dose is
considered protective |
After a booster at
1 yr revaccination once every 3
yrs or more is considered protective. |
Core:
Demonstrated cross-protection against canine hepatitis
caused by CAV-1 as well as CAV-2 one of the agents
- known to be associated with infectious
tracheobronchitis. Adult dogs challenged 7 yrs following
vaccination were protected
|
| Canine Adenovirus-2
(CAV-2) killed or topical |
|
|
|
Not
recommended. CAV-2 (MLVparenteral)
vaccines
- produce a more effective immune
response than CAV-2 killed vaccines do.
|
| Rabies 1-year
killed |
Administer one dose
as early as 3 months of age |
RABIES-1YR
Administer a single dose |
Annually,
State and local laws apply. The 1-yr rabies
vaccine may be used as booster vaccine when dogs are
required by statute to be vaccinated annually. |
State, and local
statutes govern the frequency of vacciness for products
labeled as 1 yr vaccines. The 1 yr rabies vaccine is
sometimes administered as the initial dose followed by a 1
year later by administration of the 3 yr rabies
vaccine. State statute governs. 1 yr vaccine
should not be considered to cause fewer adverse reactions
than a 3 yr rabies products. Route of administration is not
optional. |
| Rabies-3 yr killed |
Administer one dose
as early as 3 months of age where authorized by law a 3 yr
vaccine may be substituted as alternative to the 1 yr
vaccine for intial and subsequent doses |
RABIES-3YR
Administer a single dose. Where
authorized by local and state statures a 3 yrrabies vaccine
may be substituted as an alternative to the 1 yr
vaccine for intial and subsequent doses. |
The second rabies
vaccination is recommended 1 year following the
adminsitration fo the initial dose regardless of the animals
age at the time the first dose was given . Booster
vaccines should be given every 3 yrs. State and local laws
may apply |
State and local
laws govern statutes the frequency of giving the 3 yrs
rabies vaccine. The 1 yr vaccine is sometimes given as
the initial dose follwoed 1 yr later by the 3 yr rabies
vaccine. |
| Parainfluenza Virus
(CPIV) (MLV parenteral) |
Administer at 6-8
wks of age then every 3-4 wks until 12-14 wks of age |
One dose is
adequate. |
After a booster at
1 yr revaccination once
every 3 years is protective. |
DOI by challenge
has been shown to be at least 1 yr for topical intranasal
vaccine. |
| Bordetella
bronchiseptica)killed bacterin-parental) |
Administer one dose
at 6-8 wks and one dose at 1-12 wks of age |
KENNEL
COUGH
Two doses 2-4 weeks apart. |
Annually
or more often in very high -risk animals not protected by
annual booster. |
There is no known
advantage to giving parenteral and intrranasal B vaccines
simultaneously. Vaccine should be given at least 1 wk
prior to exposure. |
| Bordetella
bronchiseptica(live arirulent bacteria) + Parainfluenza
?Virus (MLV) topical intranasal application |
Administer a single
dose as early as 3 wks of age for best results a second dose
should be given 2-4 wks after the first |
KENNEL
COUGH
A single dose is recommended |
Annually.
or more often in very high -risk animals not protected by
annual boosters |
Transient 3-10
coughing, sneezing, or nasal discharge may occur in small
percentage of vaccinates. If animal has not been
vaccinated within the previous 6 months a booster is
recommended 1 week prior to known exposure. |
| Bordetella
bronchiseptica(cell wall antigen extract)parenteral |
Administer one dose
at 8 wks of age and one dose at 12 weeks of age |
KENNEL
COUGH
Two doses 4 weeks apart |
Annually
or up to every 6 months in high risk environments |
DOI is apprx.
9-12 months There is no known advantage to giving parenteral
and internasal simultaneously. |
| Bomelia (Lyme)
killed whole bacteria |
Intital dose may be
given at 9-12 wks of age with a 2nd dose 2-4 wks later |
LYME
DISEASE FROM TICKS
Two doses 2-4 wks apart |
Annually
Revaccinate prior to start of tick season as determined by
region |
Recommended only
for use in dogs that known high risk of exposure living in
an area where tick exposure is high. Minimum challenge
is 1 yr in studies |
| Canine Doronavirus
(CCV) (killed and MLV) |
|
|
|
Not
recommended--Prevalence of clinical cases of
confirmed CCV disease does not justify vaccination.
Clinical disease rarely occurs and when seen is typically
mild and self-limiting. Experience has shown no
additional increase in infectious erteritis amoung adults or
puppies subsequent to discontinuing CCV vaccines
Neither the MLV vaccine nor the killed CCV vaccine have been
shown to protect dogs against challenge when these tow
viruses are used |
| Leptospira
interrogans(combined with serovars canicola and
icterohaemorrhaglae killed bacteria) |
Administer one dose
at 12 wks and one dose at 14-16 wks for optimal
response. Do not give to dogs younger than 12 weeks. |
Two doses 2-4 wks
apart. |
Annual boosters are
not routinely
recommended for all dogs. Vaccinations should
be restricted to use in areas where a reasonable risk of
exposure is established. Vets are advised of anecdotal
reports of acute anaphylaxis in toy breeds following
adminstration of leptospirosis vaccines. Routine
vaccination of toy breeds should only be considered in dogs
with known high risks. Dogs at high risk should be
vaccinated at 12and 16wks of age.and then at intervals of
6-9 months until the risk is reduced. |
Disease prevalence
is likely to vary for each serovar. Vaccine
recommendations are therefore difficult to make die to lack
of information on prevalence of specific serovar infections
in fogs in various geographic regions. Anecdotal
reports from vets and breeders suggest that incidence of
post vaccination reactions (acute anaphylaxis) in puppies
(<12 wks of age ) and small breed dogs is high.
Reactions are most severe in young puppies. Therefore,
routine use of the vaccine should be delayed until dogs are
12 wks of age. Minimum DOI based on challenge studies
has been shown to be approx 1 year for serovars. |
| Giardia |
|
|
|
Not
recommended the vaccine may prevent cyst shedding but
does not prevent infection. There is insufficient date
to warrant routine use of this vaccine. |
| Crotalus atrox
Toxid |
|
|
|
used to protect
dogs against venom of snake bite and should be used only
in areas associated with rattlesnakes |
Porphyromonas
- peridontal disease
|
|
|
|
intended ONLY
as an act to prevent peridontal disease in dogs |